James S. McGinley, Ph.D.
Affiliations: | 2014 | Psychology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Psychometrics PsychologyGoogle:
"James McGinley"Mean distance: 24.62 (cluster 26)
Parents
Sign in to add mentor| Patrick J. Curran | grad student | 2014 | UNC Chapel Hill | |
| (A novel mixed effects modeling framework for longitudinal ordinal substance use data.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Houts CR, McGinley JS, Wirth RJ, et al. (2020) Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 study. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation |
| Houts CR, Wirth RJ, McGinley JS, et al. (2020) Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT-6) Total and Item-Specific Scores in Chronic Migraine. Headache |
| Houts CR, Wirth RJ, McGinley JS, et al. (2019) Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative Review. Headache |
| McGinley JS, Buse DC, Shulman KJ, et al. (2019) Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized Trial. Headache |
| McGinley JS, Wirth RJ, Houts CR. (2019) Growth Curves for Headache Research: A Multilevel Modeling Perspective. Headache |
| Schenkel EJ, Messina JC, Bodine A, et al. (2018) Disease Burden of Chronic Rhinosinusitis (CRS) is as Severe as Other Serious Chronic Diseases Journal of Allergy and Clinical Immunology. 141: AB165 |
| Burns AR, Hussong AM, Solis JM, et al. (2017) Examining Cohort Effects in Developmental Trajectories of Substance Use. International Journal of Behavioral Development. 41: 621-631 |
| Lipton RB, McGinley JS, Shulman KJ, et al. (2017) AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial. Headache |
| Lipton RB, McGinley JS, Shulman KJ, et al. (2017) Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study. Headache |
| McGinley JS, Curran PJ, Hedeker D. (2015) A novel modeling framework for ordinal data defined by collapsed counts. Statistics in Medicine. 34: 2312-24 |